Hong Kong Zhang Zhongjing Group

Hong Kong Zhang Zhongjing Group Limited is a Hong Kong-based subsidiary of the prominent Chinese pharmaceutical firm Zhongjing Wanxi Pharmaceutical, established in 2023. The company serves as a strategic international hub for the registration, distribution, and wholesale of traditional Chinese medicine (TCM) products, including proprietary Chinese medicines and herbal materials. It holds dual wholesale licenses in Hong Kong, enabling it to manage a comprehensive supply chain from raw materials to finished products like Liuwei Dihuang Pills and Xiaoyao Pills. The group is central to its parent company's internationalization strategy, aiming to expand the reach of the "Zhongjing" brand into Southeast Asia and other global markets. Through its operations in Hong Kong, the company bridges traditional medical wisdom with modern regulatory standards to provide high-quality healthcare solutions.